1. A compound bolt for securing a frit to a piston head in a preparative chromatography column, said compound bolt comprising:
a hollow outer bolt having first and second ends;
a filler bolt insertable into said outer bolt and means for sealing said filler bolt inside said outer bolt to prevent fluid passage through said outer bolt; and
a rod insertable through said outer bolt when said filler bolt is not residing inside said outer bolt, said rod being of sufficient length to protrude beyond both said first and second ends of said outer bolt and bearing indicia such that the length of said rod protruding beyond said first end of said outer bolt is determinable by reading indicia on said rod protruding beyond said second end of said outer bolt.
2. The compound bolt of claim 1 further comprising an internal shoulder in said outer bolt positioned to abut an end of said filler bolt when said filler bolt is inserted in said outer bolt, and wherein said means for sealing said filler bolt is a gasket on said internal shoulder.
3. The compound bolt of claim 1 wherein said outer bolt has a threaded exterior and a threaded interior, and said filler bolt has a threaded exterior to mate with said threaded interior of said outer bolt.
4. A method for lowering a piston head over a bed of particulate material in a preparative chromatography column, said method comprising:
(a) with said piston head positioned above said bed but not in contact therewith and a hollow bolt securing a frit to a lower surface of said piston head, inserting a graduated rod through said hollow bolt until a lower end of said graduated rod contacts said bed, and observing indicia on said graduated rod exposed above said hollow bolt as an indication of the length of said graduated rod extending between said hollow bolt and said bed;
(b) removing said graduated rod;
(c) lowering said piston head by a selected distance related to said observed indicia; and
(d) inserting a plug in said hollow bolt in place of said graduated rod to seal said hollow bolt against entry of fluid.
5. The method of claim 4 wherein step (d) is performed prior to step (c).
6. The method of claim 4 wherein said plug is a filler bolt and said hollow bolt has an internal shoulder positioned to abut an end of said filler bolt, and step (d) further comprises compressing a gasket between said shoulder and said end of said filler bolt to seal said hollow bolt.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. An expandable stent, comprising bioabsorbable material and a coating, wherein the expandable stent comprises a plurality of first meandering strut patterns forming an interconnected mesh, and at least one second strut pattern comprising a hoop circumferential about the longitudinal axis of the expandable stent, wherein the second strut pattern crystallizes when the stent is expanded, and wherein the coating comprises a ligand.
2. The expandable stent of claim 1, wherein the second strut pattern further comprises a through-void.
3. The expandable stent of claim 1, wherein the bioabsorbable material comprises at least poly-L-lactide (PLLA).
4. The expandable stent of claim 1, wherein the ligand is configured to bind target cells in vivo.
5. The expandable stent of claim 4, wherein the ligand is a small molecule, a peptide, an antibody, antibody fragments, or combinations thereof and the target cell is a progenitor endothelial cell antigen.
6. The expandable stent of claim 1, wherein the bioabsorbable matrix comprises a natural or synthetic biodegradable polymer.
7. The expandable stent of claim 1, wherein the bioabsorbable matrix comprises at least one of the group consisting of: dextran, tropoelastin, elastin, laminin, fibronectin, fibrin, collagen, basement membrane proteins, and cross-linked tropoelastin.
8. The expandable stent of claim 1, comprising a pharmacological substance.
9. The expandable stent of claim 8, wherein the pharmacological substance is at least one of the group consisting of: cyclosporin A, mycophenolic acid, mycophenolate mofetil acid, rapamycin, rapamycin derivatives, biolimus A9, CCI-779, RAD 001, AP23573, azathioprene, pimecrolimus, tacrolimus (FK506), tranilast, dexamethasone, corticosteroid, everolimus, retinoic acid, vitamin E, rosglitazone, simvastatins, fluvastatin, estrogen, 17\u03b2-estradiol, hydrocortisone, acetaminophen, ibuprofen, naproxen, fluticasone, clobetasol, adalimumab, sulindac, dihydroepiandrosterone, testosterone, puerarin, platelet factor 4, basic fibroblast growth factor, fibronectin, butyric acid, butyric acid derivatives, paclitaxel, paclitaxel derivatives, LBM-642, deforolimus, and probucol.